![Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014299914005780-gr3.jpg)
Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect
![Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway](https://www.spandidos-publications.com/article_images/or/39/3/OR-39-03-1081-g05.jpg)
Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway
![Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance](https://oaepublishstorage.blob.core.windows.net/421bb4a8-c0a0-457f-b3c5-bd4bcf29c3f8/3688.fig.2.jpg)
Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance
![Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014299914005780-gr2.jpg)
Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect
![Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective | SpringerLink Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00280-016-3003-0/MediaObjects/280_2016_3003_Fig1_HTML.gif)
Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective | SpringerLink
![Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness](https://www.spandidos-publications.com/article_images/ijo/47/1/IJO-47-01-0398-g08.jpg)
Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness
![Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors | Pharmacogenomics Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.12.81/asset/images/medium/figure1.gif)
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors | Pharmacogenomics
![Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? | British Journal of Cancer Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6603860/MediaObjects/41416_2007_Article_BF6603860_Fig1_HTML.jpg)
Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? | British Journal of Cancer
![SciELO - Brasil - Carboplatin: molecular mechanisms of action associated with chemoresistance Carboplatin: molecular mechanisms of action associated with chemoresistance SciELO - Brasil - Carboplatin: molecular mechanisms of action associated with chemoresistance Carboplatin: molecular mechanisms of action associated with chemoresistance](https://minio.scielo.br/documentstore/2175-9790/9F6tZpxsm7spMKjGn6Z3kvr/edd47f9119c4c21b35b0e77d5cb3663f3e376e13.png)
SciELO - Brasil - Carboplatin: molecular mechanisms of action associated with chemoresistance Carboplatin: molecular mechanisms of action associated with chemoresistance
![Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014299914005780-gr1.jpg)
Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer - ScienceDirect
![Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer | Cell Death & Disease Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-021-04118-4/MediaObjects/41419_2021_4118_Figa_HTML.png)
Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer | Cell Death & Disease
![Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance](https://oaepublishstorage.blob.core.windows.net/421bb4a8-c0a0-457f-b3c5-bd4bcf29c3f8/3688.fig.4.jpg)
Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance
![Metabolism of pancreatic cancer: paving the way to better anticancer strategies | Molecular Cancer | Full Text Metabolism of pancreatic cancer: paving the way to better anticancer strategies | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-020-01169-7/MediaObjects/12943_2020_1169_Fig3_HTML.png)
Metabolism of pancreatic cancer: paving the way to better anticancer strategies | Molecular Cancer | Full Text
![Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC](https://www.jcancer.org/v13/p0034/toc.jpg)
Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC
![Frontiers | OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma | Oncology Frontiers | OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma | Oncology](https://www.frontiersin.org/files/Articles/698302/fonc-11-698302-HTML/image_m/fonc-11-698302-g006.jpg)
Frontiers | OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma | Oncology
![Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation | Journal of Pharmacology and Experimental Therapeutics Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/377/3/370/F1.large.jpg)
Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation | Journal of Pharmacology and Experimental Therapeutics
![Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma | Cancer Cell International | Full Text Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma | Cancer Cell International | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12935-019-0767-4/MediaObjects/12935_2019_767_Fig6_HTML.png)